131 related articles for article (PubMed ID: 7699471)
1. Renal clearance of technetium-99m-MAG3: normal values.
Russell CD; Li Y; Nadiye Kahraman H; Dubovsky EV
J Nucl Med; 1995 Apr; 36(4):706-8. PubMed ID: 7699471
[No Abstract] [Full Text] [Related]
2. How gender and age affect iodine-131-OIH and technetium-99m-MAG3 clearance.
Bagni B; Bagni I; Orsolon P; Corazzari T
J Nucl Med Technol; 2000 Sep; 28(3):156-8. PubMed ID: 11001496
[TBL] [Abstract][Full Text] [Related]
3. Normal ranges of renal physiological parameters for technetium-99m mercaptoacetyltriglycine and the influence of age and sex using a camera-based method.
Lin WY; Changlai SP; Kao CH
Urol Int; 1998; 60(1):11-6. PubMed ID: 9519415
[TBL] [Abstract][Full Text] [Related]
4. 99mTc-mercaptoacetyltriglycine camera-based measurement of renal clearance: should the result be normalized for body surface area?
Klingensmith WC
J Nucl Med Technol; 2013 Dec; 41(4):279-82. PubMed ID: 24167023
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of Tc-99m cystine and Tc-99m MAG3 in normals and patients with renal functional impairment.
Misra M; Pradhan PK; De K; Chandra S; Das BK
Clin Nucl Med; 2009 Mar; 34(3):141-5. PubMed ID: 19352274
[TBL] [Abstract][Full Text] [Related]
6. Residual kidney function after donor nephrectomy. Assessment by 99mTc-MAG3-clearance.
Hamscho N; Wilhelm A; Döbert N; Menzel C; Gossmann J; Berner U; Zaplatnikov K; Scheuermann EH; Grünwald F
Nuklearmedizin; 2005; 44(5):200-4. PubMed ID: 16395496
[TBL] [Abstract][Full Text] [Related]
7. [Simultaneous measumrement of the renal excretion of 131I-hippuran and 99mTc-MAG3].
Schroth HJ; Bialy J; Bühler M; Peters JW; Rink T; Schmidt M; Garth H
Nuklearmedizin; 1994 Jun; 33(3):113-8. PubMed ID: 8090625
[TBL] [Abstract][Full Text] [Related]
8. Multicenter trial validation of a camera-based method to measure Tc-99m mercaptoacetyltriglycine, or Tc-99m MAG3, clearance.
Taylor A; Manatunga A; Morton K; Reese L; Prato FS; Greenberg E; Folks R; Kemp BJ; Jones ME; Corrigan PE; Galt J; Eshima L
Radiology; 1997 Jul; 204(1):47-54. PubMed ID: 9205222
[TBL] [Abstract][Full Text] [Related]
9. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.
Taylor A; Ziffer JA; Steves A; Eshima D; Delaney VB; Welchel JD
Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734
[TBL] [Abstract][Full Text] [Related]
10. Renal nuclear medicine: a review.
Daniel GB; Mitchell SK; Mawby D; Sackman JE; Schmidt D
Vet Radiol Ultrasound; 1999; 40(6):572-87. PubMed ID: 10608684
[TBL] [Abstract][Full Text] [Related]
11. Quantitative renal scintigraphic determination of effective renal plasma flow in dogs with normal and abnormal renal function, using 99mTc-mercaptoacetyltriglycine.
Itkin RJ; Krawiec DR; Twardock AR; Gelberg HB
Am J Vet Res; 1994 Dec; 55(12):1660-5. PubMed ID: 7887507
[TBL] [Abstract][Full Text] [Related]
12. Determination of the technetium-99m mercaptoacetyltriglycine plasma clearance in children by means of a single blood sample: a multicentre study. The Paediatric Task Group of the EANM.
Piepsz A; Gordon I; Hahn K; Kolinska J; Kotzerke J; Sixt R
Eur J Nucl Med; 1993 Mar; 20(3):244-8. PubMed ID: 8462614
[TBL] [Abstract][Full Text] [Related]
13. Effects of radiofrequency ablation on individual renal function: assessment by technetium-99m mercaptoacetyltriglycine renal scintigraphy.
Mukai T; Sato S; Iguchi T; Mimura H; Yasui K; Gobara H; Saika T; Nasu Y; Kumon H; Kanazawa S
Acta Med Okayama; 2006 Apr; 60(2):85-91. PubMed ID: 16680184
[TBL] [Abstract][Full Text] [Related]
14. A theoretical four-compartment model to evaluate separate kidney technetium-99m-MAG3 kinetics in humans.
Curti G; DeMartini D; Santaniello B; Taddei G; Fresco GF
Kidney Int; 1998 Dec; 54(6):2029-36. PubMed ID: 9853268
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the single-injection plasma disappearance of technetium-99m mercaptoacetyltriglycine method for determination of effective renal plasma flow in dogs with normal or abnormal renal function.
Itkin RJ; Krawiec DR; Twardock AR; Gelberg HB; Koritz GD
Am J Vet Res; 1994 Dec; 55(12):1652-9. PubMed ID: 7887506
[TBL] [Abstract][Full Text] [Related]
16. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
Kabasakal L; Turoğlu HT; Onsel C; Ozker K; Uslu I; Atay S; Cansiz T; Sönmezoğlu K; Altiok E; Isitman AT
J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
[TBL] [Abstract][Full Text] [Related]
17. The kidney: imaging with Tc-99m mercaptoacetyltriglycine, a technetium-labeled analog of iodohippurate.
Russell CD; Thorstad BL; Stutzman ME; Yester MV; Fowler D; Dubovsky EV
Radiology; 1989 Aug; 172(2):427-30. PubMed ID: 2526350
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Tc-99m MAG3 dynamic renal scintigraphy with an aneurysmal type renal arteriovenous fistula.
Horita Y; Nakamura S; Hirashima S; Tadokoro M; Taura K; Suyama N; Sakamoto I; Nishikido M; Miyazaki M; Kohno S
Clin Nucl Med; 2003 May; 28(5):429-31. PubMed ID: 12702950
[No Abstract] [Full Text] [Related]
19. Measurement of renal function with technetium-99m-MAG3 in children and adults.
Russell CD; Taylor AT; Dubovsky EV
J Nucl Med; 1996 Apr; 37(4):588-93. PubMed ID: 8691246
[TBL] [Abstract][Full Text] [Related]
20. Re: Taylor et al.: a 7% decrease in the differential renal uptake of MAG3 implies a loss in renal function (Urology 2010;76:1512-1516).
Zuckier LS
Urology; 2011 Apr; 77(4):1011; author reply 1011-2. PubMed ID: 21477735
[No Abstract] [Full Text] [Related]
[Next] [New Search]
